The ongoing armed conflict between Israel and the armed Palestinian faction, Hamas, has sent shock waves through the Middle East. Accordingly, major South Korean companies like Samsung Electronics and Hyundai Motor, which have a significant presence in the area, are closely monitoring the situation.
Recent data shows that South Korea’s top revenue-generating corporations have collectively invested a total of 4.5 trillion won (US$3.38 billion) in stakes in other companies, including ventures and startups, over the past 2 years and 6 months. The sector that received the highest concentration of i
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) has visited the SK bioscience headquarters and signed a memorandum of understanding (MOU) with the compa
President Yoon Suk-yeol has picked up the biotech industry as a future growth driver and is determined to support it. To this end, the government’s budget for biotech R&D for 2024 has been expanded by 12 percent. Starting from 2024, the government will launch large-scale R&D projects to develop vacc
The Korean government is approving the sale of national core technologies to foreign companies, national core technology transfers, or foreign investment in national core technology holding organizations after receiving reports on them. The number of such cases has more than tripled over the last fi
Koo Kwang-mo, the CEO of LG Group, has embarked on reviewing the progresses and strategies for cultivating future growth areas like biotechnology and artificial intelligence (AI).From Aug. 21 (local time) and over the course of four days, Koo visited Boston, the U.S., and Toronto, Canada, to assess
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today that the company has entered into a collaboration agreement with Vaxxas, an Australian biotechnology company developing a unique vaccine patch platform technology, to
Companies investing in biopharmaceutical-related technologies and production facilities will now be eligible for a maximum tax deduction of 35 percent.On July 27, the Ministry of Economy and Finance held the 56th session of the Tax System Advancement Review Committee presided over by Deputy Prime Mi
The government has designated seven specialized complexes for the nation’s advanced strategic industries such as semiconductors, secondary batteries, and displays. In addition to this, five specialized complexes for materials, parts and equipment have also been newly designated to focus on five othe
A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.Through joint research with the Korea Institute of Machinery and Materials (President Sang Jin Park, hereinafter referred to as KI
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Although SK Biopharm’s operating losses likely narrowed q-q in 2Q23, we believe that COGS-to-sales ratio returned to the previous high level, and SG&A expenses likely upped q-q on clinical costs. How
Nine merger and acquisition (M&A) deals worth more than US$1 billion were made in the global pharmaceutical and bio industries in the first half of this year.According to the Korea Biotechnology Industry Organization (KBIO) on July 2, the global pharmaceutical and bio industries recorded nine M&A de
Samsung Chairman Lee Jae-yong, SK Chairman Chey Tae-won, Hyundai Motor Chung Eui-sun, and LG Chairman Koo Kwang-mo discussed bilateral cooperation on energy, biotechnology and future transportation in a meeting with French President Emmanuel Macron.The Korean business leaders met with President Macr
The Korean government will announce a plan to ease special listing requirements for excellent companies with cutting-edge technologies in the semiconductor, bio, artificial intelligence, and secondary battery sectors in July.The Financial Services Commission (FSC) will map out the plan by forming a
Pharmaceutical and biotech companies from Korea will be attending the “2023 Bio International Convention” held in Boston, Massachusetts, the U.S., from June 5 to 8. The convention is the largest biotech and pharmaceutical exhibition in the world and is organized by the Biotechnology Innovative Organ
The United Arab Emirates (UAE), which pledged US$30 billion in investment in Korea during a bilateral summit in January, has set out to make that investment in Korea. It is reviewing investment opportunities worth US$2 billion in Korea, focusing on priority investment cooperation areas such as energ
The author is an analyst of NH Investment & Securities. He can be reached at dongyang.kim@nhqv.com -- Ed.Earnings at Samsung C&T have leveled up thanks to stable earnings at the construction division, brisk growth at the bio division, and the fading of Covid-19 effects. Based on this, Samsung C&T ha
On April 13, POSCO International announced a new vision for the first time after its integration with POSCO Energy at the Songdo Convensia in Incheon. Under the vision of Green Energy & Global Business Pioneer, the company aims to increase its current market capitalization from 3.8 trillion won to 2
The European Patent Office announced on March 28 that South Korean enterprises’ patent applications in Europe increased 10 percent to 10,367 last year. The number topped 10,000 for the first time and the rate of increase was second only to that of Chinese enterprises (15.1 percent).U.S. enterprises’
TiumBio Co., an R&D-focused clinical-stage biotechnology company based in South Korea, today announced the publication of two posters that will be presented during the upcoming 2023 American Association for Cancer Research Annual Meeting (AACR 2023), taking place from April 14th in Orlando, Florida.